$113 Million is the total value of Virtus ETF Advisers LLC's 261 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FNCL | New | FIDELITYmsci finls idx | $1,408,000 | – | 35,927 | +100.0% | 1.24% | – |
| VSTM | New | VERASTEM INC | $985,000 | – | 143,188 | +100.0% | 0.87% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $933,000 | – | 68,587 | +100.0% | 0.82% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $884,000 | – | 66,701 | +100.0% | 0.78% | – |
| ALBO | New | ALBIREO PHARMA INC | $876,000 | – | 24,688 | +100.0% | 0.77% | – |
| CCXI | New | CHEMOCENTRYX INC | $841,000 | – | 63,829 | +100.0% | 0.74% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $814,000 | – | 76,173 | +100.0% | 0.72% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC COM | $797,000 | – | 36,223 | +100.0% | 0.70% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $796,000 | – | 20,154 | +100.0% | 0.70% | – |
| SRNE | New | SORRENTO THERAPEUTICS INC | $783,000 | – | 108,716 | +100.0% | 0.69% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $779,000 | – | 19,795 | +100.0% | 0.69% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $774,000 | – | 65,221 | +100.0% | 0.68% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $768,000 | – | 441,461 | +100.0% | 0.68% | – |
| ECYT | New | ENDOCYTE INC | $764,000 | – | 55,345 | +100.0% | 0.68% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $763,000 | – | 143,951 | +100.0% | 0.68% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $762,000 | – | 24,374 | +100.0% | 0.67% | – |
| FATE | New | FATE THERAPEUTICS INC | $749,000 | – | 66,073 | +100.0% | 0.66% | – |
| MNOV | New | MEDICINOVA INC | $746,000 | – | 93,768 | +100.0% | 0.66% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $741,000 | – | 37,750 | +100.0% | 0.66% | – |
| UTSL | New | DIREXION SHS ETF TRdly utlties 3x | $727,000 | – | 28,402 | +100.0% | 0.64% | – |
| PGNX | New | PROGENICS PHARMACEUTICALS IN | $725,000 | – | 90,177 | +100.0% | 0.64% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $680,000 | – | 44,617 | +100.0% | 0.60% | – |
| TORC | New | RESTORBIO INC | $673,000 | – | 73,570 | +100.0% | 0.60% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $658,000 | – | 69,305 | +100.0% | 0.58% | – |
| SYRS | New | SYROS PHARMACEUTICALS INC | $630,000 | – | 61,719 | +100.0% | 0.56% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $609,000 | – | 49,734 | +100.0% | 0.54% | – |
| TECL | New | DIREXION SHS ETF TRdly tech bull 3x | $586,000 | – | 4,399 | +100.0% | 0.52% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $362,000 | – | 31,061 | +100.0% | 0.32% | – |
| AVGO | New | BROADCOM INC | $35,000 | – | 145 | +100.0% | 0.03% | – |
| NVDA | New | NVIDIA CORP | $26,000 | – | 109 | +100.0% | 0.02% | – |
| TWTR | New | TWITTER INC | $20,000 | – | 449 | +100.0% | 0.02% | – |
| HTHT | New | HUAZHU GROUP LTDsponsored ads | $14,000 | – | 325 | +100.0% | 0.01% | – |
| SWKS | New | SKYWORKS SOLUTIONS INC | $14,000 | – | 140 | +100.0% | 0.01% | – |
| TMUS | New | T MOBILE US INC | $12,000 | – | 193 | +100.0% | 0.01% | – |
| FLR | New | FLUOR CORP NEW | $12,000 | – | 244 | +100.0% | 0.01% | – |
| JOBS | New | 51JOB INC | $7,000 | – | 76 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.